In the first part of the podcast, Dr. Jason Crowell discusses the AAN Guideline Subcommittee's practice guideline summary on dopaminergic therapy for motor symptoms in early Parkinson disease with Dr. Anthony Lang (00:45). In the second segment, Dr. Kathryn Nevel talks with Dr. Amanda Guidon about the development of consensus disease definitions for neurologic immune-related adverse events associated with immune checkpoint inhibitors (17:04).